|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 14/745 | |||
| C07K 16/36 |
| (11) | Number of the document | 2297207 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09766879.2 |
| Date of filing the European patent application | 2009-06-19 | |
| (97) | Date of publication of the European application | 2011-03-23 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/NL2009/050361 |
| Date | 2009-06-19 |
| (87) | Number | WO 2009/154461 |
| Date | 2009-12-23 |
| (30) | Number | Date | Country code |
| 73882 P | 2008-06-19 | US |
| (72) |
Hack, Erik, NL
|
| (73) |
Prothix BV,
Warmonderweg 23, 2334 AB Leiden,
NL
|
| (54) | USE OF ANTI-FACTOR XI ANTIBODIES FOR PREVENTION OR TREATMENT OF THROMBUS FORMATION |
| USE OF ANTI-FACTOR XI ANTIBODIES FOR PREVENTION OR TREATMENT OF THROMBUS FORMATION |